First real-world evidence shows long term benefits of sublingual immunotherapy to control allergic rhinitis and potentially prevent allergic asthma
Allergic rhinitis is a common, chronic, and often debilitating condition that impacts approximately 500 million people globally, putting these patients at greater risk for developing allergic asthma